Publications by authors named "Nicolas Sabarth"

Claim this Profile
L
LY6G6D is a selectively expressed colorectal cancer antigen that can be used for targeting a therapeutic T-cell response by a T-cell engager.
Leticia Corrales, Susanne Hipp, Katharina Martin, Nicolas Sabarth, Iñigo Tirapu

Front Immunol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD206+ tumor-associated macrophages cross-present tumor antigen and drive antitumor immunity.
Madhura Modak, Ann-Kathrin Mattes, Daniela Reiss, Wioletta Skronska-Wasek, Rebecca Langlois, Nicolas Sabarth

JCI Insight· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of an Antibody Light Chain Framework Enhances Expression, Biophysical Properties and Pharmacokinetics.
Patrice Douillard, Michael Freissmuth, Gerhard Antoine, Michael Thiele, Daniel Fleischanderl, Nicolas Sabarth

Antibodies (Basel)· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of the Cysteine 81 Residue of Macrophage Migration Inhibitory Factor as a Molecular Redox Switch.
Alexander Schinagl, Randolf J Kerschbaumer, Nicolas Sabarth, Patrice Douillard, Peter Scholz

Biochemistry· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cell culture-derived whole-virus H5N1 vaccine induces long-lasting cross-clade protective immunity in mice which is augmented by a homologous or heterologous booster vaccination.
Nicolas Sabarth, Helga Savidis-Dacho, Michael G Schwendinger, Peter Brühl, Daniel Portsmouth

Vaccine· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A vero cell-derived whole-virus H5N1 vaccine effectively induces neuraminidase-inhibiting antibodies.
Richard Fritz, Nicolas Sabarth, Stefan Kiermayr, Christine Hohenadl, M Keith Howard

J Infect Dis· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
H5N1 whole-virus vaccine induces neutralizing antibodies in humans which are protective in a mouse passive transfer model.
M Keith Howard, Nicolas Sabarth, Helga Savidis-Dacho, Daniel Portsmouth, Otfried Kistner

PLoS One· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of homologous rather than heterologous antigen-specific CD4 T cell responses is critical for functional CD8 T cell responses in mice transgenic for a foreign antigen.
Nicolas Sabarth, Louise Chamberlain, Sara Brett, John Tite, Jenny Craigen

J Immunol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizations.
Annett Hessel, Michael Schwendinger, Daniela Fritz, Sogue Coulibaly, Georg W Holzer, Nicolas Sabarth

PLoS One· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of different injection routes and schedules of IC41, a Hepatitis C virus (HCV) peptide vaccine.
Christa Firbas, Thomas Boehm, Vera Buerger, Elisabeth Schuller, Nicolas Sabarth

Vaccine· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seasonal influenza vaccine elicits heterosubtypic immunity against H5N1 that can be further boosted by H5N1 vaccination.
André van Maurik, Nicolas Sabarth, Helga Savidis Dacho, Peter Brühl, Michael Schwendinger

Vaccine· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models.
Otfried Kistner, Brian A Crowe, Walter Wodal, Astrid Kerschbaum, Helga Savidis-Dacho, Nicolas Sabarth

PLoS One· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of single, homologous prime-boost and heterologous prime-boost immunization strategies against H5N1 influenza virus in a mouse challenge model.
Nicolas Sabarth, M Keith Howard, Helga Savidis-Dacho, André van Maurik, P Noel Barrett

Vaccine· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonreplicating vaccinia virus vectors expressing the H5 influenza virus hemagglutinin produced in modified Vero cells induce robust protection.
Josef Mayrhofer, Sogue Coulibaly, Annett Hessel, Georg W Holzer, Michael Schwendinger, Nicolas Sabarth

J Virol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Helicobacter pylori surface proteins by selective proteinase K digestion and antibody phage display.
Nicolas Sabarth, Robert Hurvitz, Monika Schmidt, Ursula Zimny-Arndt, Peter R Jungblut

J Microbiol Methods· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of murine and human immunoproteomes of Helicobacter pylori validates the preclinical murine infection model for antigen screening.
Dirk Bumann, Petra Holland, Frank Siejak, Jan Koesling, Nicolas Sabarth

Infect Immun· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of surface proteins of Helicobacter pylori by selective biotinylation, affinity purification, and two-dimensional gel electrophoresis.
Nicolas Sabarth, Stefanie Lamer, Ursula Zimny-Arndt, Peter R Jungblut, Thomas F Meyer

J Biol Chem· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteome analysis of secreted proteins of the gastric pathogen Helicobacter pylori.
Dirk Bumann, Sevil Aksu, Meike Wendland, Katharina Janek, Uschi Zimny-Arndt, Nicolas Sabarth

Infect Immun· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis